Challenging the 20% Rule: Is a Fixed Cutoff Still Appropriate for Elective Neck Dissection in cN0 Necks?
BACKGROUND: The 20% occult metastasis threshold proposed by Weiss in 1990 has long guided elective neck dissection (END) in clinically node-negative (cN0) head and neck cancer, despite advances in surgical safety and oncologic evidence. METHODS: An international web-based cross-sectional survey evaluated acceptable risk thresholds and attitudes toward END among head and neck (HN) surgeons, other healthcare professionals, and non-healthcare participants. The primary outcome was the acceptable occult metastasis risk to justify END; secondary outcomes included acceptable 5-year mortality increase and complication trade-offs. RESULTS: Of 2077 responses, 2008 were analyzed. Overall, 55% would undergo END at ≤ 10% occult metastasis risk and 86% at 20%. Responses differed significantly across groups (p < 0.0001), with lower thresholds among HN surgeons; 57% endorsed END at ≤ 10% and 92% at ≤ 20%. Among HN surgeons, a threshold of 5% or lower was considered sufficient to include the following levels in the dissection: 78% of surgeons for Level IIB, 75% for Level IV, and 69% for Level V. The majority of HN surgeons (90%) considered it more appropriate to calculate the individual risk and discuss the indication with the patient rather than relying on a fixed threshold. CONCLUSIONS: Most respondents-particularly HN surgeons-favor lower thresholds than the historical 20%, supporting individualized risk-based decision-making rather than reliance on a fixed cut-off.
Authors
- Katarzyna Fułek (ORCID: https://orcid.org/0000-0002-1147-774X)
- Shalva R Gvetadze (ORCID: https://orcid.org/0000-0003-3806-9022)
- Luca Giovanni Locatello (ORCID: https://orcid.org/0000-0002-1879-5580)
- Domenico Amadio (ORCID: https://orcid.org/0000-0001-7534-0024)
- Matteo Di Bari (ORCID: https://orcid.org/0000-0002-4028-7187)
- Çağrı Becerik (ORCID: https://orcid.org/0000-0003-3889-7143)
- Aina Brunet (ORCID: https://orcid.org/0000-0003-0713-3765)
- Andrea Galli (ORCID: https://orcid.org/0000-0003-2677-8091)
- Hazan Başak (ORCID: https://orcid.org/0000-0002-9973-7170)
- Elisa Laura (ORCID: https://orcid.org/0000-0003-4110-5426)
- Ignacio Javier Fernandez (ORCID: https://orcid.org/0000-0002-9120-6586)
- Magda Barańska (ORCID: https://orcid.org/0000-0002-2674-9197)
- Leison Maharjan (ORCID: https://orcid.org/0000-0001-5242-7653)
- Amaya Roldán Fidalgo (ORCID: https://orcid.org/0000-0002-1727-816X)
- Vittorio Rampinelli (ORCID: https://orcid.org/0000-0002-0901-6266)
- Federico Giuseppe Quarta
- Pasquale D’Alessio (ORCID: https://orcid.org/0000-0001-6339-3778)
- Sarah Atallah (ORCID: https://orcid.org/0000-0001-8702-1119)
- Dorota Świątek (ORCID: https://orcid.org/0000-0003-4787-4269)
- Samuel Oluyomi Ayodele (ORCID: https://orcid.org/0000-0002-1703-6427)
- Luca Gazzini (ORCID: https://orcid.org/0000-0002-5077-9847)
- Laith Dahoun
- Daniele Borsetto (ORCID: https://orcid.org/0000-0003-3464-2688)
- Virginia Dallari (ORCID: https://orcid.org/0000-0001-9260-1003)
- Francesca Zanghi (ORCID: https://orcid.org/0009-0003-0249-8527)
- P. Pérez-Chacón (ORCID: https://orcid.org/0009-0000-9111-4342)
- Ana Penezić (ORCID: https://orcid.org/0000-0002-0256-4403)
- Diana Ugorová
- Carola Gillone
- Olga Komiażyk
- Eleonora Trecca
- Kylian Ladrière
- Giulia Gobbo (ORCID: https://orcid.org/0009-0005-1056-1383)
- Nikola Đorđević (ORCID: https://orcid.org/0009-0002-7053-8132)
- Y‐CEORL GROUP
- Luca Calabrese
- Ismail S. Nouh (ORCID: https://orcid.org/0000-0002-9609-7446)
- Marco Zaraca (ORCID: https://orcid.org/0009-0003-5629-2954)
Institutions
- University of Foggia (IT)
- University of Verona (IT)
- University of Udine (IT)
- Cliniques Universitaires Saint-Luc (BE)
- Patan Academy of Health Sciences (NP)
- Ankara University (TR)
- University of Nis (RS)
- Vita-Salute San Raffaele University (IT)
- Central European University (AT)
- King Hussein Medical Center (JO)
- Cambridge University Hospitals NHS Foundation Trust (GB)
- Bandırma Onyedi Eylül University (TR)
- Wroclaw Medical University (PL)
- Sorbonne Université (FR)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Hospital Son Llatzer (ES)
- Ospedale Santa Chiara (IT)
- Ospedale di Bolzano (IT)
- Ospedale "Santa Maria delle Croci" di Ravenna (IT)
- University Hospital Bratislava (SK)
- Mercy University Hospital (IE)
- Surgical Specialties (Canada) (CA)
- Ospedale Civile Di Ivrea (IT)
- Catholic University of Croatia (HR)
- Azienda Ospedaliera Santa Maria Degli Angeli (IT)
- CTO Andrea Alesini (IT)
- Medical University of Lodz (PL)
- Central Clinical Hospital (PL)
- P.A. Hertzen Moscow Oncology Research Institute (RU)
- Łukasiewicz Research Network – PORT Polish Center for Technology Development (PL)
- Azienda Ospedaliera di Desio e Vimercate (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Obafemi Awolowo University Teaching Hospitals Complex (NG)
- Hospital Universitario Río Hortega (ES)
- Azienda Ospedaliera Ospedale Civile di Legnano (IT)
- Ospedale Civile di Vittorio Veneto (IT)
- Hôpital Tenon (FR)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- Obafemi Awolowo University (NG)
- Comenius University Bratislava (SK)
- University of Brescia (IT)
- Alexandria University (EG)
- University of Bologna (IT)
Publication Details
- Journal
- Head & Neck
- Published
- 2026-08-26
- DOI
- https://doi.org/10.1002/hed.70444
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00